29.08.2022 - Hofseth BioCare ASA is yet again part of an Exclusive Short-List of Companies to Have Successfully Notified FDA while receiving a No Objection Letter for ProGo Bioactive Peptides. Summary Highlights of the FDA’s NDI Process for HBC and what it . Seite 1
Hofseth BioCare ASA is yet again part of an Exclusive Short-List of Companies to Have Successfully Notified FDA while receiving a No Objection Letter for.